D.C. Ride-a-thon – On August 1, Jim Barth, a multiple myeloma patient, will begin his ride on his scooter from Clearwater, FL to the International Myeloma Foundation (IMF) Seminar in Washington, D.C. Jim is looking for sponsors to help raise funds for the IMF and the Tampa – St. Petersburg Multiple Myeloma Education Group. The IMF Seminar will be held on August 7 and 8. For more information, please visit Jim’s Web site. Donations may be made on his page.

5430 Long Course Triathlon – On August 9, the 5430 Long Course Triathlon will begin at 6:30 a.m. and end at 3:30 p.m. The triathlon will be held in Boulder, CO, and the Leukemia & Lymphoma Society’s Team In Training (TNT) will be participating. To join Team In Training for the Triathlon, please visit the TNT Web site.

Ontario Approves Funding For Revlimid – On July 24 the Ontario government approved funding for Revlimid (lenalidomide) to be used with dexamethasone (Decadron) for multiple myeloma patients. This makes Ontario the second Canadian province to fund Revlimid, following British Columbia. Myeloma Canada is now urging other provinces to follow the examples set by the two provinces. For more information, please visit the CNW Group Web site.

For a more detailed listing of myeloma related events, please check the Myeloma Beacon Events Calendar.